111 results
8-K
EX-10.8
o2qzy
19 Sep 22
Entry into a Material Definitive Agreement
4:31pm
8-K
EX-10.3
tkg9daovy96
19 Sep 22
Entry into a Material Definitive Agreement
4:31pm
8-K
EX-10.1
r01r2
19 Sep 22
Entry into a Material Definitive Agreement
4:31pm
8-K
EX-1.1
6ybs4ur6l9i
15 Oct 21
Entry into a Material Definitive Agreement
4:17pm
8-K
EX-99.1
ap1cs1 ti10megw
27 Sep 21
Company Anticipates Part B of MOMENTUM to Serve as Pivotal Study for SRP-5051 and to Seek Accelerated Approval if Successful
8:34am
8-K
EX-99.1
qsobxs5c3f0p
3 May 21
Results suggest a highly potent next-generation treatment that could offer greater efficacy with less frequent dosing
8:52am